Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Net Margin (2016 - 2025)

Angiodynamics (ANGO) has disclosed Net Margin for 16 consecutive years, with 7.99% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin rose 675.0% year-over-year to 7.99%, compared with a TTM value of 9.02% through Nov 2025, up 6942.0%, and an annual FY2025 reading of 11.62%, up 4904.0% over the prior year.
  • Net Margin was 7.99% for Q4 2025 at Angiodynamics, up from 14.4% in the prior quarter.
  • Across five years, Net Margin topped out at 58.32% in Q3 2023 and bottomed at 249.71% in Q1 2024.
  • Average Net Margin over 5 years is 22.1%, with a median of 11.21% recorded in 2023.
  • The sharpest move saw Net Margin crashed -23796bps in 2024, then surged 24359bps in 2025.
  • Year by year, Net Margin stood at 10.67% in 2021, then rose by 7bps to 9.93% in 2022, then plummeted by -270bps to 36.74% in 2023, then surged by 60bps to 14.74% in 2024, then skyrocketed by 46bps to 7.99% in 2025.
  • Business Quant data shows Net Margin for ANGO at 7.99% in Q4 2025, 14.4% in Q3 2025, and 7.55% in Q2 2025.